S

Silence Therapeutics

London, United Kingdom Founded 1994 NASDAQ: SLN

About

Pioneer in precision RNAi medicines using mRNAi GOLD platform with GalNAc delivery

Company Details

Type
commercial
Employees
100-200
Funding
Public

Key Products

  • Zerlasiran
  • mRNAi GOLD Platform
Visit Website

Related Companies